We've found
1,719
archived clinical trials in
Diabetic Neuropathy
We've found
1,719
archived clinical trials in
Diabetic Neuropathy
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
Updated: 8/29/2017
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
Updated: 8/29/2017
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
Updated: 8/29/2017
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
Updated: 8/29/2017
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
Updated: 8/29/2017
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
Updated: 8/29/2017
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Updated: 9/7/2017
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Study of LY3016859 in Participants With Diabetic Nephropathy
Updated: 9/7/2017
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Updated: 9/7/2017
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Study of LY3016859 in Participants With Diabetic Nephropathy
Updated: 9/7/2017
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Updated: 9/7/2017
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Study of LY3016859 in Participants With Diabetic Nephropathy
Updated: 9/7/2017
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Updated: 9/7/2017
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Study of LY3016859 in Participants With Diabetic Nephropathy
Updated: 9/7/2017
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Updated: 9/7/2017
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Study of LY3016859 in Participants With Diabetic Nephropathy
Updated: 9/7/2017
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Updated: 9/7/2017
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Study of LY3016859 in Participants With Diabetic Nephropathy
Updated: 9/7/2017
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Updated: 9/7/2017
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Study of LY3016859 in Participants With Diabetic Nephropathy
Updated: 9/7/2017
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Click here to add this to my saved trials
Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)
Updated: 10/4/2017
Randomized Open Label Study Comparing the Metabolic Control of Kidney Transplant Recipients With Type 2 Diabetes Receiving Either Prograf or Neoral as Part of a ATG Induction, Prednisone Free and Monitored MMF Immunosuppressive Regimen.
Status: Enrolling
Updated: 10/4/2017
Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)
Updated: 10/4/2017
Randomized Open Label Study Comparing the Metabolic Control of Kidney Transplant Recipients With Type 2 Diabetes Receiving Either Prograf or Neoral as Part of a ATG Induction, Prednisone Free and Monitored MMF Immunosuppressive Regimen.
Status: Enrolling
Updated: 10/4/2017
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Updated: 10/5/2017
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
A Study in Participants With Diabetic Kidney Disease
Updated: 11/17/2017
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials